RxDoctor Payments DataLook up a doctor →

Rajsekar Rajaraman

Neurology with Special Qualifications in Child Neurology · Los Angeles, CANPI 1104144690

Payments from drug & device makers

$1,484,677in general payments, 2019–2025

Across 392 payments — averaging $3787.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Genentech, Inc.$372K
  • Immedica Pharma US, Inc.$330K
  • Ultragenyx Pharmaceutical Inc.$315K
  • UCB SA$139K
  • Takeda Pharmaceuticals U.S.A., Inc.$134K
  • Jazz Pharmaceuticals Inc.$65K
  • plus $130K from 23 others

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,484,677 in reported general payments places this provider in the 95th percentile of 216 neurology with special qualifications in child neurology providers in California.

See all neurology with special qualifications in child neurology providers in California

Other neurology with special qualifications in child neurology in Los Angeles

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →